Current Assets Изменить Дата
Abbott USD 23.51B 872M 2023-06
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
Enanta Pharmaceuticals USD 422.79M 25.67M 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Heron Therapeutics USD 193.98M 28.7M 2023-09
Insmed USD 929.06M 2.49M 2023-12
Integra LifeSciences USD 1.06B 30.81M 2023-12
Intrexon USD 92.99M 12.64M 2023-09
J&J USD 53.7B 6.86B 2023-09
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Merit Medical Systems USD 1.11B 523.15M 2023-12
Peregrine Pharmaceuticals USD 104.2M 5.89M 2023-09
Rigel Pharmaceuticals USD 95.02M 5.9M 2023-09
Smith & Nephew USD 3.88B 22M 2023-06
Stryker USD 12.49B 1.44B 2023-12
Surmodics USD 86.69M 841K 2023-09
Veracyte USD 285.62M 14.46M 2023-12
Xencor USD 623.16M 51.98M 2023-12
Zimmer Biomet Holdings USD 4.61B 237.5M 2023-12



Anika Therapeutics Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.